MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.fertnstert.2015.02.003

Медицинская библиотека · Fertility and sterility · 2015

Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.

Caanen Mirte R, Soleman Remi S, Kuijper Esther A M, Kreukels Baudewijntje P C, De Roo Chloë, Tilleman Kelly, De Sutter Petra, van Trotsenburg Mick A A, Broekmans Frank J, Lambalk Cornelis B

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To investigate the effect of hormonal androgenic treatment on antimüllerian hormone (AMH) serum levels in female-to-male (FtM) transsexuals. Polycystic ovary syndrome (PCOS) is associated with elevated AMH levels. Some hypothesize that the high AMH level is a consequence of androgen-induced excessive development of small antral follicles. However, this role of androgens is not yet clear.

DESIGN

Observational, prospective, cohort study.

SETTING

Tertiary academic medical center.

PATIENT(S): Twenty-two FtM transsexuals, healthy native females receiving cross-sex hormone therapy/androgenic treatment.

INTERVENTION(S): Androgenic treatment with testosterone (T) and an aromatase inhibitor while endogenous hormone secretion was suppressed with the use of a GnRH agonist.

MAIN OUTCOME MEASURE(S): Hormone concentrations were measured before and after androgenic treatment (administration of T and aromatase inhibitor). Measured hormones: AMH, inhibin B, T, androstenedione, DHEAS, E2, SHBG, LH, and FSH.

RESULT(S): AMH concentrations were significantly lower after androgenic treatment (4.4 ± 4.4 μg/L vs. 1.4 ± 2.1 μg/L). Androgenic treatment resulted in a strong suppression of AMH secretion over a relative short period of 16 weeks.

CONCLUSION(S): Our data underscore the likely important role of androgens in the dynamics of folliculogenesis. It challenges the idea that androgens induce high AMH levels, which is gaining more interest nowadays as an important particular PCOS feature. This strong decline furthermore indicates that AMH must be interpreted in the context of other reproductive endocrine conditions.

CLINICAL TRIAL REGISTRATION NUMBER: NTR2493.

Для цитирования: Caanen Mirte R, Soleman Remi S, Kuijper Esther A M, Kreukels Baudewijntje P C, De Roo Chloë, Tilleman Kelly, De Sutter Petra, van Trotsenburg Mick A A, Broekmans Frank J, Lambalk Cornelis B. Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy.. Fertility and sterility. 2015. DOI: 10.1016/j.fertnstert.2015.02.003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.